Platelet formation is the consequence of caspase activation within megakaryocytes

Stephane De Botton1, Siham Sabri, Eric Daugas

  • 1Institut National de la Santé et de la Recherche Médicale U362 and the Centre National de la Recherche Scientifique (Unité Mixte de Recherche 1599), Institut Gustave Roussy, Institut Fédératif de Recherche 54, Villejuif, France.

Blood
|August 1, 2002
PubMed

Insights

Localized caspase activation, a key part of programmed cell death, is essential for the formation of proplatelets from megakaryocytes (MKs). This controlled process differs from widespread apoptosis, enabling platelet production.

Area of Science:

  • Hematology
  • Cell Biology
  • Molecular Biology

Background:

  • Platelets are crucial for hemostasis and are produced by megakaryocytes (MKs).
  • Proplatelet formation involves cytoplasmic extensions from mature MKs, followed by MK apoptosis.
  • The role of apoptosis, specifically caspases, in regulating proplatelet formation is not fully understood.

Purpose of the Study:

  • To investigate the role of caspases in human megakaryocyte (MK) proplatelet formation.
  • To determine if localized caspase activation is involved in proplatelet biogenesis.

Main Methods:

  • Human MKs were differentiated from CD34(+) cells.
  • Immunoblots were used to detect caspase maturation and substrate cleavage.
  • Mitochondrial membrane permeabilization and DNA fragmentation were assessed.
  • Caspase inhibitors and Bcl-2 overexpression were employed to study the effects on proplatelet formation.

Main Results:

  • Activated caspase-3 and caspase-9, along with cleaved substrates like gelsolin and PARP, were detected in maturing and proplatelet-bearing MKs.
  • Localized caspase-3 activation, associated with cytochrome c release but not DNA fragmentation, occurred before proplatelet formation.
  • Diffuse caspase activation, linked to DNA fragmentation, inhibited proplatelet formation.
  • Caspase inhibition (z-VAD.fmk, caspase-3, and caspase-9 inhibitors) blocked proplatelet formation, while calpeptin had no effect.
  • Bcl-2 overexpression also inhibited proplatelet formation.

Conclusions:

  • Localized caspase activation is a critical and causal event in proplatelet formation.
  • Proplatelet formation is regulated by caspase activity confined to specific cellular compartments, distinct from the diffuse activation seen in general apoptosis.
  • This compartmentalized caspase activation is essential for efficient platelet biogenesis.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...